Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 5.02T | 4.83T | 3.83T | 3.12T | 2.88T |
Gross Profit | 1.08T | 1.04T | 801.52B | 687.70B | 613.64B |
EBITDA | 283.42B | 419.51B | 247.92B | 192.12B | 98.58B |
Net Income | 114.08B | 207.70B | 142.81B | 81.56B | -31.65B |
Balance Sheet | |||||
Total Assets | 4.09T | 3.79T | 3.26T | 2.97T | 2.92T |
Cash, Cash Equivalents and Short-Term Investments | 1.21T | 922.56B | 717.10B | 740.39B | 739.00B |
Total Debt | 723.00B | 575.79B | 627.13B | 680.81B | 755.93B |
Total Liabilities | 2.28T | 2.03T | 1.80T | 1.65T | 1.72T |
Stockholders Equity | 1.79T | 1.74T | 1.44T | 1.30T | 1.18T |
Cash Flow | |||||
Free Cash Flow | 177.36B | 303.65B | 38.30B | 49.80B | 34.02B |
Operating Cash Flow | 305.63B | 418.89B | 137.42B | 189.16B | 120.06B |
Investing Cash Flow | -199.96B | -179.89B | -99.43B | -136.24B | -78.86B |
Financing Cash Flow | 90.07B | -84.70B | -89.86B | -86.41B | 99.35B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $256.13B | 9.15 | 12.05% | 2.74% | 4.14% | -12.12% | |
77 Outperform | $54.57B | 11.97 | 5.17% | 4.09% | 1.68% | -39.28% | |
75 Outperform | $55.98B | 9.24 | 7.07% | 0.87% | 5.34% | -28.29% | |
73 Outperform | $47.12B | 15.11 | 7.11% | 6.30% | 2.72% | -17.58% | |
73 Outperform | $4.29B | 33.33 | 1.11% | 4.93% | -1.09% | -91.34% | |
61 Neutral | $17.75B | 12.56 | -5.49% | 3.02% | 1.43% | -14.12% | |
57 Neutral | $13.21B | ― | -240.42% | ― | 23.39% | 3.93% |